NCT00081874 2025-04-27RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell LymphomaM.D. Anderson Cancer CenterPhase 1/2 Completed29 enrolled